Related Experiment Video
Updated: Jun 20, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
TumorOriginPredictor: A Clinically Validated and Cloud-Deployed AI Platform for Tissue-of-Origin Identification in
Saicharan Vellanki1, Paraic A Kenny2
1Issaquah High School, Issaquah, Washington, USA.
Summary
Cancer of Unknown Primary (CUP) diagnosis is challenging. A new AI tool, TumorOriginPredictor, uses genomic data to accurately predict tumor origins, improving cancer treatment and patient survival.
Area of Science:
- Oncology
- Genomics
- Artificial Intelligence
Background:
- Cancer of Unknown Primary (CUP) presents a significant diagnostic challenge, accounting for 3-5% of US cancer diagnoses.
- Accurate tumor origin identification is crucial for effective treatment, but histological methods often fail in metastatic cases.
- Empirical therapies for CUP can be toxic and ineffective due to the lack of a confirmed primary site.
Purpose of the Study:
- To develop and validate an AI-powered platform, TumorOriginPredictor, for accurate tumor origin prediction using somatic mutation data.
- To improve diagnostic accuracy for Cancer of Unknown Primary (CUP) cases, thereby guiding more effective and personalized cancer treatments.
Main Methods:
- Developed TumorOriginPredictor, a machine learning platform trained on 10,945 MSK-IMPACT mutation profiles.
- Implemented five predictive models generating rank-ordered probabilities for the top three predicted tumor origins.
- Validated the platform using 770 real-world clinical profiles and deployed it on the Azure cloud for real-time predictions.
Main Results:
- TumorOriginPredictor achieved over 72% top-3 accuracy across 12 cancer types and exceeded 80% accuracy for prevalent cancers.
- The platform demonstrated clinical validity and provides interpretable, rank-ordered probability predictions.
- Real-time prediction capability was established through cloud deployment.
Conclusions:
- TumorOriginPredictor offers a scalable and trustworthy AI solution for diagnosing Cancer of Unknown Primary (CUP).
- Accurate tumor origin prediction facilitates individualized treatment, reducing reliance on empirical therapies.
- The platform has the potential to decrease healthcare costs, save time, and improve patient survival rates.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
